Blog

Over the life of a study, the amount of time and resources spent on changes to a system can significantly impact the study – but do they have to?

Did you know that Phase 1 trials can be even more complex than their Phase 2 and 3 counterparts? Don't let scale be the determining factor in choosing to leverage an RTSM. Here are 5 questions to ask when you consider an RTSM for your next Phase 1 study.

Having an IRT/RTSM for your IITs will help with supply chain management since IITs traditionally draw from the same pool of drugs as manufacturer-sponsored studies. See how.

On Wednesday, June 26th, 4G Clinical co-founders David Kelleher and Ed Tourtellotte were recognized as finalists for EY’s Entrepreneur Of The Year ®2019 Award for the New England region. An impressive group of unstoppable entrepreneurs from 36 companies across many industries celebrated entrepreneurship throughout the evening at the Westin Waterfront hotel in Boston.

Here are the top 5 reasons you should attend CBI's IRT conference on Interactive Response Technologies in Clinical Trials.